It has been demonstrated that the release of CMV interleukin-10 (CMV IL-10), a homolog of human IL-10 that is associated with higher-grade gliomas and may exacerbate a tumor’s invasive potential, is induced upon the in vitro infection of glioma cancer stem cells by human CMV [37,38]. The gene discussed is IL10; the disease is central nervous system cancer.